| Pharmaceutical active ingredients: |
| Budesonide |
| Available forms, composition and doses of Rhinocort Hayfever: |
| Spray; Nasal; Budesonide 32 mcg / dose |
| Rhinocort Hayfever medical category: |
| Human:AdrenalsAntiasthmatic and COPD preparationsAnti-inflammatory agentsCorticosteroidsNasal decongestants and other nasal preparationsTopical corticosteroids used as nasal decongestants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A07EA06 - BudesonideR01AD05 - Budesonide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| AstraZeneca |
| Related documents and information about Rhinocort Hayfever: |
| Rhinocort AstraZeneca prescribing information (PDF)Rhinocort Aqua prescribing information (PDF) |